What the changes say
- New risks focus on evolving U.S. cannabinoid rules, including CBD, Delta-9 THC and THCA, that could eliminate product categories.
- BrewDog U.S. acquisition approvals and integration may delay or reduce expected strategic benefits.
- Self-insurance and Middle East instability add potential claims costs and European energy-cost pressure.
- Nasdaq compliance, reverse-split uncertainty and warrant financing risks were removed.
What changed since the prior 10-K
New
- NewRisks Related to the Cannabis Business
United States regulations relating to cannabinoid products, including CBD, Delta-9 THC, THCA and other cannabinoids, are rapidly evolving, and recent federal and state legislative developments may materially restrict or eliminate certain product categories and adversely affect our business objectives
Changing U.S. federal, state and local rules could restrict or eliminate hemp-derived cannabinoid and medical cannabis products.
- NewRisks related to the Beverage Business
Our ability to complete the BrewDog U.S. acquisition is subject to regulatory approvals, and we may face risks associated with integrating all of the acquired BrewDog businesses
Regulatory approval or integration problems could delay the BrewDog U.S. acquisition, disrupt operations or prevent expected synergies.
- NewRisks Related to Ongoing Litigation Claims
We are self-insured for certain losses, which may expose us to significant unexpected costs and adversely affect our financial condition and results of operations
Self-insured employee health, workers’ compensation, Canadian property and other claims could exceed reserves and create significant costs.
- NewRisks Related to our Intellectual Property
Geopolitical instability involving the conflict in Iran could increase fuel and energy costs in Europe and adversely affect our operations and results
An Iran-related escalation could raise European fuel, transportation and utility costs, pressuring brewing, cultivation and operating margins.
Dropped
- DroppedRisks Related to the Cannabis Business
United States regulations relating to hemp-derived CBD products, Delta-9 products, and medical cannabis products are new and rapidly evolving, and changes may not develop in the timeframe or manner most favorable to our business objectives
- DroppedRisks Related to Ownership of Our Securities
Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities
- DroppedRisks Related to Ownership of Our Securities
There is Uncertainty Regarding the Impact of Tilray Implementing a Reverse Stock Split
- DroppedRisks Related to Ownership of Our Securities
The terms of our outstanding warrants may limit our ability to raise additional equity capital or pursue acquisitions, which may impact funding of our ongoing operations and cause significant dilution to existing stockholders
Reworded
- 76% rewrittenRisks Related to our Intellectual Property
Tax and accounting requirements may change in ways that are unforeseen to us and we may face difficulty or be unable to implement or comply with any such changes
The heading now expressly highlights difficulty implementing or complying with unforeseen tax and accounting changes; the discussion is otherwise unchanged.
- 71% rewrittenRisks Related to Ongoing Litigation Claims
We are subject to litigation, arbitration and demands, which could result in significant liability and costs, and impact our resources and reputation
The risk now additionally identifies derivative litigation, securities class actions and contractual disputes among potential claims.
- 32% rewrittenRisks Related to the Cannabis Business
Our cannabis business is dependent upon regulatory approvals and licenses, ongoing compliance and reporting obligations, and timely renewals
No substantive wording change; the Canadian cannabis licensing, export approval and renewal risk remains the same.
All 59 risk factors
Headings as the filing states them, in filing order.
Risks Related to the Cannabis Business
- 01Our cannabis business is dependent upon regulatory approvals and licenses, ongoing compliance and reporting obligations, and timely renewals32% rewritten
- 02Competition from the illicit cannabis market could impact our ability to succeed
- 03Our production and processing facilities are integral to our business and adverse changes or developments affecting our facilities may have an adverse impact on our business
- 04We face intense competition, and anticipate competition will increase, which could hurt our business
- 05The cannabis industry and market are relatively new and evolving, which could impact our ability to succeed in this industry and market
- 06Regulations constrain our ability to market and distribute our products in Canada and Europe
- 07Research regarding the health effects of cannabis is in relatively early stages and subject to further study which could impact demand for cannabis products
- 08United States regulations relating to cannabinoid products, including CBD, Delta-9 THC, THCA and other cannabinoids, are rapidly evolving, and recent federal and state legislative developments may materially restrict or eliminate certain product categories and adversely affect our business objectivesNew
Risks related to the Beverage Business
- 09Changes in consumer preferences or public attitudes about alcohol could decrease demand for our beverage products
- 10Developments affecting production sites, including at our breweries or our distillery in Breckenridge, could negatively impact financial results for our beverage business segment
- 11Our ability to complete the BrewDog U.S. acquisition is subject to regulatory approvals, and we may face risks associated with integrating all of the acquired BrewDog businessesNew
- 12Sweetwater, Breckenridge, Montauk, BrewDog and our other recently-acquired craft beverage brands portfolio each face substantial competition in the beer industry and the broader market for alcoholic beverage products, which could impact our business and financial results
- 13Sweetwater, Breckenridge, Montauk, BrewDog and our other recently-acquired craft beverage brands portfolio are each dependent on distributors to deliver sustained growth and distribute products
Risks Related to Ongoing Litigation Claims
- 14We are subject to litigation, arbitration and demands, which could result in significant liability and costs, and impact our resources and reputation71% rewritten
- 15The Company ’ s business may be materially adversely affected by the imposition of duties and tariffs and other trade barriers and retaliatory countermeasures implemented by the U.S. and other governments
- 16Additional impairments of our goodwill, additional impairments of our intangible and other long-lived assets, and changes in the estimated useful lives of intangible assets could have a material adverse impact on our financial results
- 17We began operating in 2014 and have yet to generate a profit. We intend to continue to expend funds to explore potential opportunities and complete strategic mergers and acquisitions, invest in research and development, expand our marketing and sales operations and meet the compliance requirements as a public company
- 18We are exposed to risks relating to the laws of various countries as a result of our international operations
- 19We are required to comply concurrently with all applicable laws in each jurisdiction where we operate or to which we export our products, and any changes to such laws could adversely impact our business
- 20Our strategic alliances and other third-party business relationships may not achieve the intended beneficial impact and expose us to risks
- 21We may not be able to successfully identify and execute future acquisitions, dispositions or other equity transactions or to successfully manage the impacts of such transactions on our operations
- 22We are subject to risks inherent in an agricultural business, including the risk of crop failure
- 23We depend on significant customers for a substantial portion of our revenue. If we fail to retain or expand our customer relationships or significant customers reduce their purchases, our revenue could decline significantly
- 24We may be unable to attract or retain key personnel, and we may be unable to attract, develop and retain additional employees required for our development and future success
- 25Increased labor costs, potential organization of our workforce, employee strikes, work stoppages, and other labor-related disruption may adversely affect our business, financial conditions and operations
- 26Significant interruptions in our access to certain supply chains for key inputs such as raw materials, aluminum, supplies, electricity, water and other utilities may impair our operations
- 27We may be negatively impacted by volatility in the political and economic environment, and a period of sustained inflation across the markets in which we operate could result in higher operating costs
- 28We face risks associated with the transportation of our products to consumers in a safe and efficient manner
- 29Our products may be subject to recalls for a variety of reasons, which could require us to expend significant management and capital resources
- 30We may be subject to product liability claims or regulatory action. This risk is exacerbated by the fact that cannabis use may increase the risk of serious adverse side effects
- 31We, or the cannabis industry more generally, may receive unfavorable publicity or become subject to negative consumer or investor perception
- 32Failure to comply with safety, health and environmental regulations applicable to our operations and industry may expose us to liability and impact operations
- 33We may experience breaches of security at our facilities, which could result in product loss and liability
- 34We may be subject to risks related to our information technology systems, including service interruption, cyber-attacks and misappropriation of data, which could disrupt operations and may result in financial losses and reputational damage
- 35The cannabis industry continues to face significant funding challenges, and we may not be able to secure adequate or reliable sources of funding, which may impact our operations and potential expansion
- 36Our existing and future debt agreements may contain covenant restrictions that limit our ability to operate our business and pursue beneficial transactions
- 37Servicing our debt will require a significant amount of cash, and we may not have sufficient cash flow from our business to pay our debt
- 38Management may not be able to successfully establish and maintain effective internal controls over financial reporting
- 39Since a significant portion of our sales are generated in Canada and other countries outside the United States, fluctuations in foreign currency exchange rates could harm our results of operations
- 40We may have exposure to greater than anticipated tax liabilities, which could harm our business
- 41We may not be able to utilize our net operating loss carryforwards which could result in greater than anticipated tax liabilities
- 42We are self-insured for certain losses, which may expose us to significant unexpected costs and adversely affect our financial condition and results of operationsNew
Risks Related to Ownership of Our Securities
- 43The price of our common stock in public markets has experienced and may continue to experience severe volatility and fluctuations
- 44The volatility of our stock and the stockholder base may hinder or prevent us from engaging in beneficial corporate initiatives
- 45If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our stock price and trading volume could decline
Risks Related to our Convertible Securities
- 46We may not have the ability to raise the funds necessary to settle conversions of the Convertible Securities in cash or to repurchase the Convertible Securities upon a fundamental change
- 47The conditional conversion feature of the Convertible Securities, if triggered, may adversely affect our financial condition and operating results
- 48Conversion of the Convertible Securities may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock
- 49Certain provisions in the indentures governing the Convertible Securities may delay or prevent an otherwise beneficial takeover attempt of us
- 50Our stockholders may be subject to dilution resulting from future offerings of common stock by us
- 51Provisions in our corporate charter documents could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our current board of directors
Risks Related to our Cryptocurrency Strategy
- 52Our cryptocurrency strategy faces high risk and uncertainty in light of market volatility and an evolving regulatory landscape
Risks Related to our Intellectual Property
- 53We may not be able to adequately protect our intellectual property
- 54We may not realize the full benefit of the clinical trials or studies that we participate in if we are unable to secure ownership or the exclusive right to use the resulting intellectual property on commercially reasonable terms
- 55We may not be able to maintain adequate insurance coverage, the premiums may not continue to be commercially justifiable, and coverage limitations or exclusions may leave us exposed to uninsured liabilities
- 56The financial reporting obligations of being a public company and maintaining a dual listing on NASDAQ and on the TSX requires significant company resources and management attention
- 57Our existing operations in the United States, and any future operations, may become the subject of heightened scrutiny by regulators, stock exchanges and other authorities in the United States and Canada
- 58Tax and accounting requirements may change in ways that are unforeseen to us and we may face difficulty or be unable to implement or comply with any such changes76% rewritten
- 59Geopolitical instability involving the conflict in Iran could increase fuel and energy costs in Europe and adversely affect our operations and resultsNew
Other Tilray Brands 10-Ks
- FY2025 10-K risk factors59 risks
Tilray's risk profile is heavily dominated by strict cannabis regulations, intense competition from illicit and licensed markets, and international operational complexity.
Filed Jul 29, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.